CARCINOID SYNDROME DIARRHEA TREATMENT MARKET ANALYSIS

Carcinoid Syndrome Diarrhea Treatment Market, By Treatment Type (Chemotherapy, Oral Therapy, and Somatostatin Analogue Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1216
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Major key players operating in the carcinoid syndrome diarrhea treatment market include Lexicon Pharmaceuticals, Inc., Novartis International AG (Sandoz), Pharmascience Inc., Omega Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Biopharmaceuticals, Inc., Sirtex Medical Limited, and BTG International Ltd.